Integra Lifesciences 

$11.11
0
-$0.27-2.37% 今天

统计

当日最高
11.18
当日最低
10.86
52周高点
-
52周低点
-
成交量
7,378
平均成交量
-
市值
865.38M
市盈率
-
股息率
-
股息
-

即将到来

财报

25Feb预期
Q3 2025
下一步
0.43
0.56
0.68
0.8
预期EPS
0.800189
实际EPS
不适用

财务

-0.43%利润率
未盈利
2019
2020
2021
2022
2023
2024
3.22B营收
-13.89M净利润

其他人也在关注

此列表基于在 Stock Events 上关注 IART.BOATS 的用户自选生成。这不是投资建议。

竞争对手

此列表为基于近期市场事件的分析。并非投资建议。

关于

Integra LifeSciences Holdings Corporation manufactures and sells surgical instrument, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals, surgery centers, dental, podiatry, and veterinary offices. In addition, the company addresses the needs of plastic, and reconstructive and general surgeons focused on the treatment of acute wounds, such as burns and chronic wounds, including diabetic foot ulcers; and provides surgical tissue repair products for hernia, tendon, peripheral nerve repair, and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. Further, it is involved in the ear, nose, and throat business that includes instrumentation, balloon technologies for sinus dilation and eustachian tube dilation, and surgical navigation systems. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, the Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
Show more...
首席执行官
Dr. Stuart M. Essig Ph.D.
员工
4396
国家
US
ISIN
US4579852082

上市

0 Comments

分享你的想法

FAQ

Integra Lifesciences 今天的股价是多少?
IART.BOATS 当前价格为 $11.11 USD,在过去 24 小时内下跌了 -2.37%。在图表上更密切关注 Integra Lifesciences 股票的表现。
Integra Lifesciences 的股票代码是什么?
根据交易所不同,股票代码可能会有所不同。例如,在 交易所,Integra Lifesciences 的股票以代码 IART.BOATS 进行交易。
Integra Lifesciences 的市值是多少?
今天 Integra Lifesciences 的市值为 865.38M
Integra Lifesciences 下一次财报日期是什么时候?
Integra Lifesciences 将于 二月 25, 2026 发布下一次财报。
Integra Lifesciences 上一季度的财报怎么样?
IART.BOATS 上季度财报为每股 0.54 USD,预估为 0.43 USD,带来 +24.37% 的意外。下季度预估财报为每股 不适用 USD。
Integra Lifesciences 去年的营收是多少?
Integra Lifesciences 去年的营收为 3.22BUSD。
Integra Lifesciences 去年的净利润是多少?
IART.BOATS 去年的净收益为 -13.89MUSD。
Integra Lifesciences 有多少名员工?
截至二月 02, 2026,公司共有4,396名员工。
Integra Lifesciences 属于哪个行业?
Integra Lifesciences从事于Health Care行业。
Integra Lifesciences 何时完成拆股?
Integra Lifesciences 最近没有进行任何拆股。
Integra Lifesciences 的总部在哪里?
Integra Lifesciences 的总部位于 US 的 Princeton。